utd_medknow
International Journal of Trichology International Journal of Trichology
 Print this page Email this page Small font sizeDefault font sizeIncrease font size
 
 
  Home | About IJT | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submission | Subscribe | Advertise | Contact us | Login   
 

    Article Cited by others

CASE REPORT

Therapy-recalcitrant folliculitis decalvans controlled successfully with adalimumab

Alhameedy Meshal M, Alsantali Adel M

Year : 2019| Volume: 11| Issue : 6 | Page no: 241-243

   This article has been cited by
 
1 Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients
Matilde Iorizzo, Michela Starace, Sergio Vano-Galvan, Bianca Maria Piraccini, Pascal Reygagne, Lidia Rudnicka, Tatiana Silyuk, Rodney Sinclair, Antonella Tosti
Journal of the American Academy of Dermatology. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Dermatoses inflammatoires et auto-immunes
C. Lenormand, N. Kluger, C. Velter
Annales de Dermatologie et de Vénéréologie - FMC. 2022; 2(2): 2/2S3
[Pubmed]  [Google Scholar] [DOI]
3 Refractory folliculitis decalvans treated with biologics: Case series in 4 situations
Alejandro Lobato-Berezo, Ramon M. Pujol
Dermatologic Therapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Therapy-refractory folliculitis decalvans treated with certolizumab pegol
Matthias Hoy, Markus Böhm
International Journal of Dermatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life
Donald E. Greydanus, Roua Azmeh, Maria Demma Cabral, Cheryl A. Dickson, Dilip R. Patel
Disease-a-Month. 2021; 67(4): 101103
[Pubmed]  [Google Scholar] [DOI]

 

Read this article